Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.33 USD | -6.98% | -11.67% | -43.75% |
04-04 | Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target | MT |
01-08 | Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.75% | 56.69M | |
+8.38% | 114B | |
+10.13% | 104B | |
-11.69% | 22.5B | |
+0.96% | 22.57B | |
-11.09% | 17.95B | |
-41.90% | 16.48B | |
-16.00% | 15.82B | |
+2.28% | 13.55B | |
+20.54% | 10.99B |
- Stock Market
- Equities
- MURA Stock
- News Mural Oncology plc
- Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target